After-Hours Stock Movers:

Outset Medical, Inc. (Nasdaq: OM) 22% LOWER; implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administrations (FDA) review and clearance of a 510(k) the company submitted for changes made since the devices original March 2020 clearance.

Oracle (NYSE: ORCL) 14% HIGHER; reported Q4 EPS of $1.54, $0.17 better than the analyst estimate of $1.37. Revenue for the quarter came in at $11.84 billion versus the consensus estimate of $11.68 billion.

Braze, Inc. (NASDAQ: BRZE) 5% HIGHER; reported Q1 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $77.5 million versus the consensus estimate of $72.57 million. Braze, Inc. sees Q2 2023 EPS of ($0.19)-($0.20), versus the consensus of ($0.21). Braze, Inc. sees Q2 2023 revenue of $80.5-81.5 million, versus the consensus of $80.13 million. Braze, Inc. sees FY2023 EPS of ($0.78)-($0.82), versus the consensus of ($0.83). Braze, Inc. sees FY2023 revenue of $345-349 million, versus the consensus of $340.29 million.